Shares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) hit a new 52-week high on Monday . The company traded as high as $54.52 and last traded at $54.52, with a volume of 5123 shares changing hands. The stock had previously closed at $54.10.
Analyst Ratings Changes
Separately, Royal Bank Of Canada raised Sandoz Group from a "hold" rating to a "moderate buy" rating in a research note on Friday, May 2nd.
Get Our Latest Stock Report on SDZNY
Sandoz Group Trading Up 1.1%
The stock has a 50 day moving average of $48.68 and a two-hundred day moving average of $45.18. The company has a quick ratio of 0.79, a current ratio of 1.24 and a debt-to-equity ratio of 0.57.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
